2 results match your criteria: "The First Hospital of Hebei Medical University Shijiazhuang 050030[Affiliation]"
Am J Transl Res
August 2024
Department of Bone Disease and Orthopedic Oncology, Yantai Yantaishan Hospital Yantai 264003, Shandong, China.
Objective: To evaluate the diagnostic value of serum alkaline phosphatase (AKP), tumor-supplied growth factor group (TSGF), and lactate dehydrogenase (LDH) for pediatric osteosarcoma.
Methods: A retrospective analysis of clinical data from 81 pediatric osteosarcoma patients (osteosarcoma group) and 63 patients with benign bone tumors (benign bone tumor group) admitted to Yantaishan Hospital from February 2023 to November 2023 was conducted. Basic and clinical data differences between the two groups of children were compared.
Int J Clin Exp Pathol
October 2016
Department of Cardiovascular Surgery, The First Hospital of Hebei Medical University Shijiazhuang 050030, P. R. China.
Purpose: We aimed to investigate the roles of miR-184 in adaptation of hypoxic cardiomyocytes, as well as to elucidate the possible mechanisms of miR-184 in the development of cyanotic congenital heart diseases (CHD).
Materials And Methods: We conducted quantitative real-time polymerase chain reaction (qRT-PCR) to determine the expression of miR-184 in patients with cyanotic cardiac defects. The embryonic rat ventricular myocardial H9c2 cells were transfected with miR-184 inhibitor and negative scramble RNA.